MISSION HILLS, LOS ANGELES (KABC) -- A medical test for kidney function that adjusts its results for race is coming under increased scrutiny. Experts are saying the results for African-American ...

In recent years, the medical community, researchers, and health policy makers have increasingly recognized that many long-established and widely used clinical decision-making tools actually perpetuate ...

Estimated glomerular filtration rate (eGFR) is linked just as tightly to chronic kidney disease (CKD) complications as the more invasive and cumbersome iothalamate GFR (iGFR) test in a recent study, ...

Novartis has spent considerable time and energy building its presence in the IgA nephropathy (IgAN) disease area, and now | ...

A race-specific algorithm designed to assess kidney function for individuals awaiting transplants jeopardized critical treatment for some Black Americans. An exclusive report by the Associated Press ...

CHICAGO -- There is new hope for thousands of African Americans waiting for a new kidney. A test to determine placement on a transplant waiting list has been deemed flawed. The finding will have a ...

HILDEN, Germany, and TOKYO--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the Japanese Pharmaceuticals and Medical Device Agency (PMDA) has approved the ...

Black Diamond Therapeutics focuses on silevertinib, a next-gen EGFR inhibitor for NSCLC, after outlicensing its other lead asset to Servier.

When her relative couldn’t get on the waiting list for a kidney transplant, Dr. Nwamaka Eneanya had to step in. Tests showed his kidney function was not severe enough. But Eneanya, a physician who ...

Tagrisso combined with chemotherapy improved overall survival in EGFR-mutated NSCLC patients, including those with poor ...

Development of an automated RNA-based nuclease protection assay for the detection of expressed EML-ALK fusions, EGFR, and KRAS mutations in NSCLC. This is an ASCO Meeting Abstract from the 2013 ASCO ...